Monitoring of clinical and laboratory data in two cases of imported Lassa fever

Microbes and Infection

Volumn 4, Issue 1, 2002, Pages 43-50

  Schmitz, Herbert ^a   Köhler, Bernhard ^b   Laue, Thomas ^c   Drosten, Christian ^a   Veldkamp, Peter J ^d   Günther, Stephan ^a   Emmerich, Petra ^a   Geisen, Hans P ^e   Fleischer, Klaus ^b   Beersma, Matthias F C ^d   Hoerauf, Achim ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b Missionsarztliche Klinik   (Germany)

^c Artus GmbH   (Germany)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Schwäbisch Hall ^*  (Germany)

Author keywords

Clinical data; Cytokine profiles; Lassa fever; Virus load

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; LACTATE DEHYDROGENASE; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASPIRATION; BLEEDING; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE COURSE; ENZYME BLOOD LEVEL; HEMORRHAGIC SHOCK; HUMAN; LASSA FEVER; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; VIREMIA; VIRUS LOAD;

ADULT; AFRICA; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CYTOKINES; FATAL OUTCOME; FEMALE; HUMANS; LASSA FEVER; LASSA VIRUS; MALE; MIDDLE AGED; RIBAVIRIN; RNA, VIRAL; TRAVEL; VIRAL LOAD; VIREMIA;

EID: 18244389013     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(01)01508-8     Document Type: Article

References (45)

1. Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea
2. A prospective study of the epidemiology and ecology of Lassa fever
3. A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972
4. Lassa fever. Epidemiological aspects of theepidemic, Jos, Nigeria
5. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings
6. Genetic diversity among Lassa virus strains
7. Imported, Lassa fever in Germany: Molecular characterization of a new Lassa virus strain
8. Lassa fever imported case, UK
9. Lassa fever, imported case, Germany
10. Lassa fever, imported case, Netherlands
11. Real-time quantitative PCR
12. Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system
13. Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies
14. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses
15. Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction
16. Early diagnosis of Lassa fever by reverse transcription-PCR
17. Lassa fever in the United States. Investigation of a case and new guidelines for management
18. An imported case of Lassa fever with late appearance of polyserositis
19. Lassa fever: The first confirmed case imported into Canada
20. Lassa fever: Response to an imported case
21. Een patient met Lassa koorts uit Opper-Volta, herkend in Nederland
22. A case-control study of the clinical diagnosis and course of Lassa fever
23. Lassa fever. Effective therapy with ribavirin
24. Lassa fever: Central neurvous system manifestations
25. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever
26. Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis
27. Proinflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease
28. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock
29. Time course and prognostic significance of hemostatic changes in sepsis: Relation to tumor necrosis factor-alpha
30. Circulating endothelin-1 and tumor necrosis factor-alpha: Early predictors of mortality in patients with septic shock
31. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are asscociated with fatal infections in acute Lassa fever
32. Tumor necrosis factor in the pathogenesis of infectious diseases
33. Role of tumor necrosis factor-alpha in disease states and inflammation
34. Tumor necrosis factor: An updated review of its biology
35. Blood interleukin 10 levels parallel the severity of septic shock
36. Monocyte deactivation-rationale for a new therapeutic strategy in sepsis
37. Proinflammatory cytokines and elastase-alpha-1-antitrypsin in Argentine hemorrhagic fever
38. Increased tumor necrosis factor-alpha levels in Argentine hemorrhagic fever letter
39. Tumor necrosis factor and the pathogenesis of Pichinde virus infection in guinea pigs
40. Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway
41. Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man
42. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways
43. Human, TNF can induce nonspecific inflammatory and human immune-mediated microvascular injury of pig skin xenografts in immunodeficient mouse hosts
44. Human asymptomatic Ebola infection and strong inflammatory response
45. Immune response to filovirus infections